Aspirin Management for Partial Mastectomy
For a partial mastectomy, aspirin should be discontinued 3 days before surgery (last dose on Day -3, with surgery on Day 0), unless the patient has high cardiovascular risk requiring continuation. 1
Clinical Decision Framework
Step 1: Assess Cardiovascular Risk
High-risk patients (continue aspirin through surgery):
- Recent coronary stent (<12 months for ACS, <6 months for stable CAD)
- History of acute coronary syndrome
- Recent stroke or TIA
- Multiple cardiovascular risk factors with established CAD
Low-risk patients (discontinue aspirin):
- Primary prevention only
- Remote cardiovascular history (>1 year)
- No recent coronary interventions
Step 2: Apply Discontinuation Protocol
For patients where discontinuation is appropriate:
Standard recommendation: 3-day washout 1
- Last aspirin dose: Day -3
- Surgery: Day 0
- This achieves adequate platelet function recovery in most patients
Important nuance: While 3 days provides sufficient platelet recovery for most breast surgery procedures, the French perioperative guidelines note that complete platelet function correction occurs by 5 days 1. However, partial mastectomy is not classified as a high-bleeding-risk procedure (unlike neurosurgery or intracranial procedures), making the 3-day window appropriate.
Step 3: Consider Patient-Specific Factors
Patients who may need longer discontinuation (5 days):
- Diabetes (accelerated platelet turnover) 1
- High body weight 1
- Myeloproliferative disorders with thrombocytosis 1
Key Evidence Points
The 2024 AHA/ACC guidelines emphasize that aspirin should be continued perioperatively when possible for patients with prior PCI to reduce cardiac events 2. However, this applies primarily to patients with coronary stents, not routine cardiovascular prevention.
For patients on aspirin for secondary cardiovascular prevention undergoing non-cardiac surgery, the POISE-2 trial showed that continuing aspirin increased bleeding without reducing cardiac events 1. This supports discontinuation for procedures where bleeding risk outweighs thrombotic risk.
Common Pitfalls to Avoid
Don't routinely order platelet function testing - No established hemostatic safety threshold exists, and testing results don't reliably predict bleeding risk in breast surgery 1
Don't bridge with heparin or other antiplatelet agents - This is not recommended and increases bleeding risk 1
Don't reduce aspirin dose perioperatively - If continuing aspirin, maintain the usual dose (75-100 mg); dose reduction provides no benefit 1
Don't delay surgery beyond necessary - The 3-day window is sufficient for partial mastectomy; unnecessary delays increase patient anxiety and may worsen outcomes
Resumption After Surgery
Resume aspirin 24-48 hours postoperatively once adequate hemostasis is confirmed and there is no ongoing bleeding concern. Earlier resumption (within 24 hours) is appropriate for high-risk cardiovascular patients.